These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1180 related items for PubMed ID: 27339253

  • 1. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and risk factors for infection after living donor liver transplantation.
    Abad CL, Lahr BD, Razonable RR.
    Liver Transpl; 2017 Apr 27; 23(4):465-477. PubMed ID: 28176451
    [Abstract] [Full Text] [Related]

  • 4. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M.
    J Gastrointest Surg; 2009 Aug 27; 13(8):1480-6. PubMed ID: 19430850
    [Abstract] [Full Text] [Related]

  • 5. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW, Katchman H, Tanaka T, Greig PD, McGilvray ID, Cattral MS, Renner EL, Selzner M, Ghanekar A, Levy G, Grant DR.
    Transpl Int; 2013 Aug 27; 26(8):780-7. PubMed ID: 23746118
    [Abstract] [Full Text] [Related]

  • 6. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan 27; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 7. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 27; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 8. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 27; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 9. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS, Ruebner RL, Abt PL.
    Am J Transplant; 2015 Oct 27; 15(10):2732-8. PubMed ID: 25969133
    [Abstract] [Full Text] [Related]

  • 10. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM.
    Liver Transpl; 2013 Mar 27; 19(3):259-67. PubMed ID: 23495079
    [Abstract] [Full Text] [Related]

  • 11. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.
    Transplant Proc; 2015 May 27; 47(4):1211-3. PubMed ID: 26036556
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED, Burrier C, Tumin D, Hayes D, Black SM, Washburn WK, Tobias JD.
    Transpl Int; 2018 Nov 27; 31(11):1200-1206. PubMed ID: 29907976
    [Abstract] [Full Text] [Related]

  • 13. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group.
    Liver Transpl; 2007 Jan 27; 13(1):122-9. PubMed ID: 17192908
    [Abstract] [Full Text] [Related]

  • 14. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis.
    Hilmi IA, Damian D, Al-Khafaji A, Sakai T, Donaldson J, Winger DG, Kellum JA.
    Liver Transpl; 2015 Sep 27; 21(9):1179-85. PubMed ID: 25980614
    [Abstract] [Full Text] [Related]

  • 15. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ, Yoo HY.
    Liver Transpl; 2004 Oct 27; 10(10):1263-8. PubMed ID: 15376301
    [Abstract] [Full Text] [Related]

  • 16. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.
    Kashyap R, Safadjou S, Chen R, Mantry P, Sharma R, Patil V, Maloo M, Ryan C, Marroquin C, Barry C, Ramaraju G, Maliakkal B, Orloff M.
    J Gastrointest Surg; 2010 Sep 27; 14(9):1362-9. PubMed ID: 20617395
    [Abstract] [Full Text] [Related]

  • 17. Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.
    Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion RM.
    Am J Transplant; 2016 Feb 27; 16(2):594-602. PubMed ID: 26461803
    [Abstract] [Full Text] [Related]

  • 18. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE, Perkins JD, Reyes JD, Montenovo MI.
    Liver Transpl; 2019 Apr 27; 25(4):580-587. PubMed ID: 29637730
    [Abstract] [Full Text] [Related]

  • 19. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
    Imai D, Yoshizumi T, Sakata K, Ikegami T, Itoh S, Harada N, Motomura T, Toshima T, Mano Y, Soejima Y, Maehara Y.
    Transplantation; 2018 Sep 27; 102(9):e382-e391. PubMed ID: 29912047
    [Abstract] [Full Text] [Related]

  • 20. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.
    Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.